“The work of dQ&A is critical. It’s one of the only ways for patients and people living with diabetes to have our voices heard regarding new technologies and innovations in care.”
Suggested Articles
Patients Weathering Chaos but Seeing Results When Starting Mounjaro, According to Proprietary dQ&A® First Look Research
Mounjaro is a once weekly injectable medicine approved for adults with type 2 diabetes to be used along with diet and exercise to improve blood sugar…
Time in Range Outcomes from Six European Countries
Our European research…
Eight dQ&A® Abstracts Presented at ATTD 2023
We are excited to announce that…